DHF
BNY MELLON HIGH YIELD STRATEGIES FUND
$2.41
0.00%
No data for this timeframe.
Vol
Inst. Holders3 funds
Inst. Value$4.4M
Inst. Activity1 buys / 2 sells
Recent Activity
Inst.
WELLS FARGO & COMPANY/MN — ADD
63,600 shares ($164.7K)
Inst.
UBS Group AG — TRIM
53,703 shares ($139.1K)
Analyst Ratings
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jul 8, 2019 | Morgan Stanley | DOWNGRADE | Overweight → Underweight |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| MORGAN STANLEY | $4.2M | — |
| WELLS FARGO & COMPANY/MN | $144.7K | ADD |
| BANK OF AMERICA CORP | $37.7K | TRIM |
3 institutional holders with $4.4M total value (1,759,785 shares) as of 2025-Q4. Top holders: MORGAN, WELLS, BANK.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 1,686,256 | $4.2M | 95.8% | — |
| 2 | WELLS FARGO & COMPANY/MN | 58,333 | $144.7K | 3.3% | ADD +29.3% |
| 3 | BANK OF AMERICA CORP /DE/ | 15,196 | $37.7K | 0.9% | TRIM -68.9% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| WELLS FARGO & COMPANY/MN | ADD | 49,202 | 63,600 | +29.3% | $164.7K | 2025-Q3 |
| UBS Group AG | TRIM | 99,880 | 53,703 | -46.2% | $139.1K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | TRIM | 48,902 | 15,196 | -68.9% | $39.4K | 2025-Q3 |
| UBS Group AG | ADD | 72,463 | 99,880 | +37.8% | $259.7K | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | ADD | 32,625 | 48,902 | +49.9% | $127.1K | 2025-Q2 |
| UBS Group AG | TRIM | 112,208 | 72,463 | -35.4% | $184.8K | 2025-Q1 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 6,235 | 43,273 | +594.0% | $110.3K | 2025-Q1 |
| CITADEL ADVISORS LLC | TRIM | 33,802 | 16,381 | -51.5% | $41.8K | 2025-Q1 |
| UBS Group AG | ADD | 77,168 | 112,208 | +45.4% | $286.1K | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | TRIM | 13,031 | 6,235 | -52.2% | $15.9K | 2024-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
1 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jul 8, 2019 | Morgan Stanley | DOWNGRADE | Overweight | Underweight |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.